Another article, there is a new predictive AI kidney disease test to be launched in the USA this year.
https://www.google.com.au/amp/s/www.cnbc.com/amp/2020/02/25/a-major-breakthrough-for-americans-on-the-brink-of-kidney-dialysis.html
At first I thought “oh no”, but when you look at the cost of the test US$950.00 on reimbursement code. What was the cost of PromarkerD $55?
Still yet to read up more on this test, but looking at the following announcement, it appears that this test is not to predict CKD before it occurs like PromarkerD, but the progression of existing kidney disease to kidney failure:
https://renalytixai.com/medicare-sets-us-national-price-for-kidneyintelx/
GLTAH
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
-0.015(4.92%) |
Mkt cap ! $47.42M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 31.0¢ | 28.5¢ | $191.2K | 643.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 53694 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 51000 | 2 |
View Market Depth
| Last trade - 15.36pm 26/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |